These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 2121848)
41. Evaluation of immunological, parasitological and molecular methods for the diagnosis of Schistosoma mansoni infection before and after chemotherapy treatment with praziquantel in experimentally infected Nectomys squamipes. Gentile R; Gonçalves MM; da Costa Neto SF; da Costa MM; Peralta RH; Peralta JM Vet Parasitol; 2011 Aug; 180(3-4):243-9. PubMed ID: 21458922 [TBL] [Abstract][Full Text] [Related]
42. Therapeutic effect of subcurative dose praziquantel on Schistosoma mansoni infected mice and resistance to challenge infection after treatment. Chaiworaporn R; Maneerat Y; Rojekittikhun W; Ramasoota P; Janecharut T; Matsuda H; Kitikoon V Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):846-52. PubMed ID: 16295535 [TBL] [Abstract][Full Text] [Related]
43. Efficacy and side effects of praziquantel in the treatment for Schistosoma mansoni infection in school children in Senbete Town, northeastern Ethiopia. Reta B; Erko B Trop Med Int Health; 2013 Nov; 18(11):1338-43. PubMed ID: 24103059 [TBL] [Abstract][Full Text] [Related]
44. Artesunate plus sulfadoxine/pyrimethamine versus praziquantel in the treatment of Schistosoma mansoni in eastern Sudan. Mohamed AA; Mahgoub HM; Magzoub M; Gasim GI; Eldein WN; Ahmed Ael A; Adam I Trans R Soc Trop Med Hyg; 2009 Oct; 103(10):1062-4. PubMed ID: 19261314 [TBL] [Abstract][Full Text] [Related]
45. Parasitological, hematological and ultrastructural study of the effect of COX-2 inhibitor, pyocyanin pigment and praziquantel, on S. mansoni infected mice. Mohamed AH; Ezz El-Din N; Fahmy ZH; El-Shennawy AM; Hassan E J Egypt Soc Parasitol; 2006 Apr; 36(1):197-220. PubMed ID: 16605111 [TBL] [Abstract][Full Text] [Related]
46. Assessment of efficacy of praziquantel against Schistosoma mansoni infection. Massoud AA; el Kholy AM; Anwar WA J Trop Med Hyg; 1984 Jun; 87(3):119-21. PubMed ID: 6512904 [TBL] [Abstract][Full Text] [Related]
47. Resistance to praziquantel, effect of drug pressure and stability test. Ismail MM; Farghaly AM; Dyab AK; Afify HA; el-Shafei MA J Egypt Soc Parasitol; 2002 Aug; 32(2):589-600. PubMed ID: 12214936 [TBL] [Abstract][Full Text] [Related]
48. Effect of a combination of the new antischistosomal drug Ro 15-5458 and praziquantel on different strains of Schistosoma mansoni infected mice. Kamel G; Metwally A; Guirguis F; Nessim NG; Noseir M Arzneimittelforschung; 2000 Apr; 50(4):391-4. PubMed ID: 10800639 [TBL] [Abstract][Full Text] [Related]
50. Schistosomiasis prevalence after administration of praziquantel to school children in Melela village, Morogoro region, Tanzania. Kitange HM; Swai AB; McLarty DG; Alberti KG East Afr Med J; 1993 Dec; 70(12):782-6. PubMed ID: 8026352 [TBL] [Abstract][Full Text] [Related]
52. Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt. Botros S; Sayed H; Amer N; El-Ghannam M; Bennett JL; Day TA Int J Parasitol; 2005 Jun; 35(7):787-91. PubMed ID: 15925597 [TBL] [Abstract][Full Text] [Related]
53. Hepatic histochemistry and electron microscopy of hamsters infected with S. mansoni and treated with praziquantel therapy. el-Hawy AM; Massoud A; el-Badrawy N; Elgaram A; Khalil A; Metwally A J Egypt Soc Parasitol; 1985 Jun; 15(1):249-62. PubMed ID: 3932526 [No Abstract] [Full Text] [Related]
54. Mass drug administration with praziquantel reduces the prevalence of Schistosoma mansoni and improves liver morbidity in untreated preschool children. Cleland CR; Tukahebwa EM; Fenwick A; Blair L Trans R Soc Trop Med Hyg; 2014 Sep; 108(9):575-81. PubMed ID: 25059523 [TBL] [Abstract][Full Text] [Related]
56. The effect of praziquantel administration on the course of hepatitis B among cases with concomitant schistosome infection. Farghaly AG; Barakat RM J Egypt Public Health Assoc; 1993; 68(1-2):81-100. PubMed ID: 8245753 [TBL] [Abstract][Full Text] [Related]
57. Pharmacokinetics of praziquantel in healthy volunteers and patients with schistosomiasis. Mandour ME; el Turabi H; Homeida MM; el Sadig T; Ali HM; Bennett JL; Leahey WJ; Harron DW Trans R Soc Trop Med Hyg; 1990; 84(3):389-93. PubMed ID: 2124391 [TBL] [Abstract][Full Text] [Related]
58. [Therapeutic effect of BILT combined with praziquantel in treatment of chronic schistosomiasis]. Ru-Yi L; Na Z; Ni-Na P; Li-le L; Yu H; Yan M; Hong-Bo W Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2017 May; 29(5):648-650. PubMed ID: 29469371 [TBL] [Abstract][Full Text] [Related]
59. Studies on liver profile after prolonged praziquantel courses for schistosomiasis mansoni in Egyptian children on a field level. el Hawey AM; Abdel Aziz T; el-Hak S; Massoud AM; Rozeik S; el-Dahrouty A; Hashim YA J Egypt Soc Parasitol; 1990 Dec; 20(2):709-19. PubMed ID: 2121848 [TBL] [Abstract][Full Text] [Related]
60. Study of some aspects of cell mediated immune response in bilharzial children on a field level. el-Hawey AM; Massoud AM; el-Rakieby A; Royzeik MS; Nassar MO J Egypt Soc Parasitol; 1991 Aug; 21(2):411-6. PubMed ID: 1908498 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]